The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.
E M Carvalho, R Badaró, S G Reed, T C Jones, W D Johnson Jr
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1973 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 2 | 1 | 1 | 3 | 2 | 1 | 5 | 3 | 8 | 4 | 7 | 7 | 6 | 12 | 7 | 6 | 5 | 9 | 9 | 10 | 6 | 6 | 5 | 5 | 9 | 12 | 5 | 3 | 5 | 11 | 19 | 11 | 10 | 7 | 7 | 8 | 8 | 3 | 2 | 1 | 253 |
Title and authors | Publication | Year |
---|---|---|
‘Active chronic visceral leishmaniasis’ in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients
N Bourgeois, P Bastien, J Reynes, A Makinson, I Rouanet, L Lachaud |
HIV Medicine | 2010 |
Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis
H Daneshvar, MM Molaei, H Kamiabi, R Burchmore, P Hagan, RS Phillips |
Parasite Immunology | 2010 |
Plasma lipoproteins in visceral leishmaniasis and their effect onLeishmania-infected macrophages
NM Soares, TF Leal, MC Fiúza, EA Reis, MA Souza, WL Dos-Santos, L Pontes-De-Carvalho |
Parasite Immunology | 2010 |
Human immunodeficiency virus and leishmaniasis
N Ezra, MT Ochoa, N Craft |
Journal of global infectious diseases | 2010 |
Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine
R Kumar, Y Goto, K Gidwani, KD Cowgill, S Sundar, SG Reed |
The American journal of tropical medicine and hygiene | 2010 |
Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis
R Nagill, S Kaur |
Vaccine | 2010 |
A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
S Mondal, P Bhattacharya, M Rahaman, N Ali, RP Goswami, P Sinnis |
PLoS neglected tropical diseases | 2010 |